Showing results 52 to 52 of 52
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Vonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial Proceeding/Conference:Digestive Disease Week 2024 (18/05/2024-21/05/2024, , , Washington, DC, USA) | 18-May-2024 |